<DOC>
	<DOCNO>NCT00725608</DOCNO>
	<brief_summary>The purpose study evaluate acceptability safety switch Suboxone速 ( buprenorphine plus naloxone ) effect switch medication dispense . Subjects , therapy Suboxone速 indicate plan prior study enrollment willing participate , initiate therapy Day 1 study . The dosage adjust Day 2 7 depend patient 's need determine treat physician accordance SmPC Suboxone速 . Data collect baseline , day 1 til 7 , end week 2 4 monthly end Month 12 .</brief_summary>
	<brief_title>Acceptability Safety Switching From Subutex Other Opioid Drug Dependence Therapy Suboxone ( NIS P05444 )</brief_title>
	<detailed_description>Nonprobability sample do invitation volunteer .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>All patient substitution therapy , willing switch Suboxone , include . Therapeutic indication contraindication Suboxone速 must take consideration select patient . According product information In accordance product information pregnant woman exclude .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Suboxone</keyword>
	<keyword>Subutex</keyword>
	<keyword>Buprenorphine</keyword>
	<keyword>Naloxone</keyword>
</DOC>